NATIONAL
CANCER
INSTITUTE

NCI Cancer Bulletin
A Trusted Source for Cancer Research News
May 30, 2006 • Volume 3 / Number 22 E-Mail This Document  |  Download PDF  |  Bulletin Archive/Search  |  Subscribe


Bulletin Home

Featured Article
New Studies Highlight the Value and Timing of Colonoscopy

Director's Update
Continuing the Legacy of a Great Leader

Spotlight
After Gleevec, Targeted Drugs Acquire More Targets

Cancer Research Highlights
RNA Interference Technique Causes Toxicity in Mice

Cryoablation for Small Renal Tumors Shows Promising Results

MRI Screening Is Cost Effective for Some BRCA Carriers

Transfusions During Surgery Linked to Cancer-Related Mortality

World No Tobacco Day Observed

Funding Opportunities

Featured Clinical Trial
Flavopiridol for Previously Treated Chronic Lymphocytic Leukemia

Notes
Joint Research Fellowships in Cancer Available

Coffee, Tea, & Chats at Mark O. Hatfield Clinical Research Center

IARC Welcomes India and Korea

Cancer Center Profile
UC Davis Cancer Center

Bulletin Archive

About the Bulletin

Page Options
Print This Page
Print This Document
View Entire Document
E-Mail This Document
View/Print PDF
Notes

Featured Meetings and Events
A calendar of scientific meetings and events sponsored by the National Institutes of Health (NIH) is available at http://calendar.nih.gov.
Joint Research Fellowships in Cancer Available
NCI and the Health Research Board of Ireland have announced a call for applications for the Joint Research Fellowships in Cancer program.

Qualified applicants include postdoctoral researchers in Ireland, Northern Ireland, and the United States working on a defined research project of mutual interest in any cancer-related discipline. Each potential research fellow must apply as part of a team, which should include an Irish principal investigator (PI) and a U.S. PI who is an NCI intramural researcher or NCI grantee.

Fellowships are awarded on a full-time basis over 2 years. Successful applicants will have the opportunity to spend 1 year with an Irish PI and 1 year with a U.S. PI. Up to five fellowships with a start date in 2007 will be awarded. Applicants must be eligible for an appropriate visa.

For more information, visit http://www.hrb.ie/display_content.php?page_id=165 and http://www.allirelandnci.org.

The deadline for this call for applications is September 1, 2006.

Coffee, Tea, & Chats at Mark O. Hatfield Clinical Research Center
Parents and families are welcome to participate in informal chats about the challenges they face while having a child in treatment at NIH's Mark O. Hatfield Clinical Research Center.

Begun by Dr. Lori Wiener of NCI's Pediatric Oncology Branch in September 2005, the chats cover a variety of topics requested by parents, such as creatively managing pain; helping other at-home siblings; nutrition; and dealing with fear, depression, and body image.

In addition to chats in English, some are conducted in Spanish, and others are open forums for families from Spanish-speaking countries.

The chats are held twice a week from 1:30 to 2:30 p.m. in 1-NW Pediatric Unit Family Room. A calendar of chats can be found outside of the clinic and 1-NW.

For additional information, please contact Dr. Wiener at 301-451-9148.

IARC Welcomes India and Korea
At its meeting on May 18, the Governing Council of the International Agency for Research on Cancer (IARC) officially greeted the Republic of India and the Republic of Korea as its 17th and 18th Participating States.

India has a long tradition in the study of cancer, and has recently made significant investments in cancer research and biotechnology. Because the population of India is growing and aging, even if the risk of cancer remains constant, there is potential for a large increase in cancer incidence. Thus, effective cancer prevention is currently a top priority.

The Republic of Korea has experienced rapid economic and social development, and cancer research and treatment have evolved rapidly. The National Cancer Centre in Seoul has excellent clinicians and researchers, and the country continues to make important investments in cancer.

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov